These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7937424)

  • 1. The role of autografting in lymphoma.
    Milligan DW; Long SG
    Postgrad Med J; 1994 Jul; 70(825):475-8. PubMed ID: 7937424
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in autologous stem cell transplantation.
    Mason JR; Ho AD
    Cancer Invest; 1997; 15(6):553-60. PubMed ID: 9412661
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone marrow and peripheral blood hematopoietic stem cell transplantation: focus on autografting.
    Baynes RD; Hamm C; Dansey R; Klein J; Cassells L; Karanes C; Abella E; Peters WP
    Clin Chem; 2000 Aug; 46(8 Pt 2):1239-51. PubMed ID: 10926918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemopoietic growth factors.
    Ketley NJ; Newland AC
    Postgrad Med J; 1997 Apr; 73(858):215-21. PubMed ID: 9156123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma.
    Bolwell BJ
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):86-95. PubMed ID: 7916488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of high-dose chemotherapy with hematopoietic stem cell transplantation for malignant lymphoma].
    Okamoto M
    Rinsho Ketsueki; 2001 Apr; 42(4):299-306. PubMed ID: 11400301
    [No Abstract]   [Full Text] [Related]  

  • 7. Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
    Majolino I; Pearce R; Taghipour G; Goldstone AH
    J Clin Oncol; 1997 Feb; 15(2):509-17. PubMed ID: 9053472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous stem cell transplantation for malignant lymphomas.
    Reményi P; Masszi T; Kriván G; Goda V; Réti M
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S104-6. PubMed ID: 9916651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous blood stem cell transplantation for Hodgkin and non-Hodgkin lymphoma: complications and outcome.
    Kumar L; Ganessan P; Ghosh I; Panda D; Gogia A; Mandhania S
    Natl Med J India; 2010; 23(6):330-5. PubMed ID: 21561042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and outcome of "hard to mobilize"' lymphoma patients undergoing autologous stem cell transplantation.
    Sugrue MW; Williams K; Pollock BH; Khan S; Peracha S; Wingard JR; Moreb JS
    Leuk Lymphoma; 2000 Nov; 39(5-6):509-19. PubMed ID: 11342334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [High-dose chemotherapy with bone marrow transplantation in recurrent or refractory NHL].
    Torello E; Koziner B
    Sangre (Barc); 1993 Dec; 38(6):473-80. PubMed ID: 7909622
    [No Abstract]   [Full Text] [Related]  

  • 12. [Autologous stem cell transplantation. From bone marrow to selected blood stem cells: 100 consecutive procedures at a single center].
    Geisler CH; Simonsen AC; Mortensen BT; Christensen LD; Ersbøll JK; Andersen NS; Dickmeiss E; Hansen MM
    Ugeskr Laeger; 1996 Apr; 158(18):2546-51. PubMed ID: 8686009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Freeze preservation of hematopoietic stem cells].
    Herve P
    Rev Fr Transfus Immunohematol; 1981 Dec; 24(6):609-30. PubMed ID: 6120560
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantity and origin of transplanted autologous blood cells are independent factors associated with speed of postransplant hematological reconstitution.
    Rogulj D; Batinić D; Nemet D; Petrovecki M
    Croat Med J; 1999 Sep; 40(3):404-8. PubMed ID: 10411969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study.
    Majhail NS; Ness KK; Burns LJ; Sun CL; Carter A; Francisco L; Forman SJ; Bhatia S; Baker KS
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1153-9. PubMed ID: 17889351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs of care and outcomes for high-dose therapy and autologous transplantation for lymphoid malignancies: results from the University of Nebraska 1987 through 1991.
    Bennett CL; Armitage JL; Armitage GO; Vose JM; Bierman PJ; Armitage JO; Anderson JR
    J Clin Oncol; 1995 Apr; 13(4):969-73. PubMed ID: 7707125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autologous transplantation of peripheral blood stem cells in malignant lymphomas].
    Sánchez Luceros A; Koziner B
    Medicina (B Aires); 1995; 55(4):366-72. PubMed ID: 8728879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose therapy with stem cell infusion in lymphoma.
    Cohen SC; Krigel RL
    Semin Oncol; 1995 Jun; 22(3):218-29. PubMed ID: 7777866
    [No Abstract]   [Full Text] [Related]  

  • 19. Hematopoietic growth factors in hematological malignancies.
    Kumar R; Rao RR; Ranjan S
    J Assoc Physicians India; 1995; Suppl 3():5-10. PubMed ID: 8773114
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of hematopoietic stem cell transplantation in the treatment of non-Hodgkin's lymphoma.
    Bierman PJ; Phillips GL
    Cancer Treat Res; 2009; 144():357-97. PubMed ID: 19779882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.